Related Experiment Videos
Platelet transfusion in aplastic patients: fatal thrombocytopenic hemorrhage in myeloblastic leukemia
J P Hester1, E H Estey, A B Deisseroth
1Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston 77030.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy
|January 1, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Long-Term Results of CAP Therapy in Chronic Lymphocytic Leukemia.
Leukemia & lymphoma·2016
[Preliminary results of the 2nd multicenter study. Thrombocytapheresis with the Fresenius AS-104 blood cell separator and ring study of cell counting. Section of Therapeutic and Preparative Hemapheresis of the DGTI].
Beitrage zur Infusionstherapie = Contributions to infusion therapy·1993
[Thrombocyte substitution in hematologic patients].
Beitrage zur Infusionstherapie = Contributions to infusion therapy·1993
[Substitution of thrombocyte concentrates in polytransfused patients].
Beitrage zur Infusionstherapie = Contributions to infusion therapy·1993
[Indications for fresh frozen plasma: evaluation of virus inactivating preparations].
Beitrage zur Infusionstherapie = Contributions to infusion therapy·1993
[Indications for irradiated blood components: dose and side effects].
Beitrage zur Infusionstherapie = Contributions to infusion therapy·1993
[Washing and filtration of blood components: which indications are established?].
Beitrage zur Infusionstherapie = Contributions to infusion therapy·1993
Prolonged low-dose intravenous thrombolysis in early recurrent stroke.
Neurologia i neurochirurgia polska·2026
HBsAg seroclearance with HBV DNA <100 IU/mL and long-term risks of adverse liver events, all-cause mortality, and cause-specific mortality in chronic hepatitis B: a prospective cohort study.
The Lancet regional health. Western Pacific·2026
Cost-effectiveness and budget impact of Luspatercept in Thai adults with transfusion-dependent beta-thalassaemia: a multi-state Markov model based on national claims data.
Journal of pharmaceutical policy and practice·2026